These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 11888585)

  • 1. Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study.
    Quéré I; Perneger TV; Zittoun J; Bellet H; Gris JC; Daurès JP; Schved JF; Mercier E; Laroche JP; Dauzat M; Bounameaux H; Janbon C; de Moerloose P
    Lancet; 2002 Mar; 359(9308):747-52. PubMed ID: 11888585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum homocysteine, thermolabile variant of methylene tetrahydrofolate reductase (MTHFR), and venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology (LITE).
    Tsai AW; Cushman M; Tsai MY; Heckbert SR; Rosamond WD; Aleksic N; Yanez ND; Psaty BM; Folsom AR
    Am J Hematol; 2003 Mar; 72(3):192-200. PubMed ID: 12605391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis.
    Koch HG; Nabel P; Junker R; Auberger K; Schobess R; Homberger A; Linnebank M; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S113-6. PubMed ID: 10650848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
    D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
    Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of homocysteine and MTHFR 677TT genotype and risk for venous thrombosis in a general population--results from the HUNT 2 study.
    Naess IA; Christiansen SC; Romundstad PR; Cannegieter SC; Blom HJ; Rosendaal FR; Hammerstrøm J
    Br J Haematol; 2008 May; 141(4):529-35. PubMed ID: 18318759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study.
    Bezemer ID; Doggen CJ; Vos HL; Rosendaal FR
    Arch Intern Med; 2007 Mar; 167(5):497-501. PubMed ID: 17353498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocystinemia in normal and thromboembolic subjects.
    Gemmati D; Previati M; Serino ML; Moratelli S; Guerra S; Capitani S; Forini E; Ballerini G; Scapoli GL
    Arterioscler Thromb Vasc Biol; 1999 Jul; 19(7):1761-7. PubMed ID: 10397696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocysteinemia and venous thromboembolism: a risk factor more prevalent in the elderly and in idiopathic cases.
    Hainaut P; Jaumotte C; Verhelst D; Wallemacq P; Gala JL; Lavenne E; Heusterspreute M; Zech F; Moriau M
    Thromb Res; 2002 Apr; 106(2):121-5. PubMed ID: 12182910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma homocysteine levels related to interactions between folate status and methylenetetrahydrofolate reductase: a study in 52 healthy subjects.
    Zittoun J; Tonetti C; Bories D; Pignon JM; Tulliez M
    Metabolism; 1998 Nov; 47(11):1413-8. PubMed ID: 9826223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients.
    Födinger M; Wölfl G; Fischer G; Rasoul-Rockenschaub S; Schmid R; Hörl WH; Sunder-Plassmann G
    Kidney Int; 1999 Mar; 55(3):1072-80. PubMed ID: 10027946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variations observed in arterial and venous thromboembolism--relevance for therapy, risk prevention and prognosis.
    Harrington DJ; Malefora A; Schmeleva V; Kapustin S; Papayan L; Blinov M; Harrington P; Mitchell M; Savidge GF
    Clin Chem Lab Med; 2003 Apr; 41(4):496-500. PubMed ID: 12747593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients.
    Gemmati D; Serino ML; Trivellato C; Fiorini S; Scapoli GL
    Haematologica; 1999 Sep; 84(9):824-8. PubMed ID: 10477457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of red-blood methylfolate but not plasma folate with C677T MTHFR polymorphism in venous thromboembolic disease.
    Quéré I; Wutschert R; Zittoun J; Bellet H; Reber G; Gris JC; Janbon C; Schved JF; de Moerloose P
    Thromb Haemost; 1998 Oct; 80(4):707-9. PubMed ID: 9798999
    [No Abstract]   [Full Text] [Related]  

  • 14. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.
    Wald DS; Law M; Morris JK
    BMJ; 2002 Nov; 325(7374):1202. PubMed ID: 12446535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations.
    Grandone E; Margaglione M; Colaizzo D; D'Andrea G; Cappucci G; Brancaccio V; Di Minno G
    Am J Obstet Gynecol; 1998 Nov; 179(5):1324-8. PubMed ID: 9822524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study of methylenetetrahydrofolate reductase C677T mutation with cerebral venous thrombosis in an Iranian population.
    Ghaznavi H; Soheili Z; Samiei S; Soltanpour MS
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):869-73. PubMed ID: 26083986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship of plasma homocysteine and folic acid levels and 5,10-methylenetetrahydrofolate reductase gene mutation with venous thromboembolism].
    Wang MT; Li Q; Han FL; Yao XP
    Zhonghua Nei Ke Za Zhi; 2004 Aug; 43(8):591-4. PubMed ID: 15355664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common C677T polymorphism in the methylenetetrahydrofolate reductase gene increases the risk for deep vein thrombosis in patients with predisposition of thrombophilia.
    Fujimura H; Kawasaki T; Sakata T; Ariyoshi H; Kato H; Monden M; Miyata T
    Thromb Res; 2000 Apr; 98(1):1-8. PubMed ID: 10706928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methionine synthase A2756G and methylenetetrahydrofolate reductase A1298C polymorphisms are not risk factors for idiopathic venous thromboembolism.
    Salomon O; Rosenberg N; Zivelin A; Steinberg DM; Kornbrot N; Dardik R; Inbal A; Seligsohn U
    Hematol J; 2001; 2(1):38-41. PubMed ID: 11920232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine, methylenetetrahydrofolate reductase polymorphism, antiphospholipid antibodies, and thromboembolic events in systemic lupus erythematosus: a retrospective cohort study.
    Fijnheer R; Roest M; Haas FJ; De Groot PG; Derksen RH
    J Rheumatol; 1998 Sep; 25(9):1737-42. PubMed ID: 9733454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.